Edition:
United States

Atcor Medical Holdings Ltd (ACG.AX)

ACG.AX on Australia Stock Exchange

0.04AUD
27 Jul 2017
Change (% chg)

$-0.01 (-14.29%)
Prev Close
$0.05
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
127,367
Avg. Vol
207,080
52-wk High
$0.14
52-wk Low
$0.04

Latest Key Developments (Source: Significant Developments)

Atcor Medical secures new pharmaceutical trials contracts
Tuesday, 11 Jul 2017 08:37pm EDT 

July 12 (Reuters) - Atcor Medical Holdings Ltd ::Secures $0.8 million new pharmaceutical trials contracts.Signed three new contracts to supply Sphygmocor systems and clinical trial support services.  Full Article

AtCor Medical Holdings signs Healthcare Delivery Network agreement with Nephrology Associates
Tuesday, 6 Jun 2017 09:33pm EDT 

June 7 (Reuters) - AtCor Medical Holdings Ltd :Asx Alert-AtCor signs new network health systems agreement-ACG.AX.Signed a healthcare delivery network agreement with Nephrology Associates of northern Illinois and Indiana.AtCor will provide SphygmoCor systems to NANI practices throughout region.  Full Article

Atcor Medical anticipates FY revenue to be between $4.3 and $5.0 mln
Thursday, 18 May 2017 12:27am EDT 

May 18 (Reuters) - Atcor Medical Holdings Ltd ::FY 17 non-pharma revenues in US are expected to grow by 15-25% year on year .Anticipates revenue for FY to be between $4.3 and $5.0 million compared with $6.182 million estimate provided on 25 Oct 2016.Board has engaged a third party to undertake a strategic review of Atcor's business.Context for review is company's continuing need for funding and likelihood that it will need to raise more capital during FY2018.  Full Article

Atcor signs local health system agreement
Wednesday, 22 Feb 2017 07:03pm EST 

Atcor Medical Holdings Ltd :Atcor signs local health system agreement.  Full Article

Atcor Medical says patent granted in USA for its brachial cuff
Tuesday, 8 Mar 2016 05:05pm EST 

Atcor Medical Holdings Ltd:Received notice of allowance from the United States patent and trademark office of a new patent "brachial cuff" in USA.Says Atcor has begun a sales campaign initially targeting four key metropolitan areas in the US.  Full Article

Atcor Medical says $0.6 mln new pharmaceutical trial contract
Thursday, 4 Feb 2016 06:43pm EST 

Atcor Medical:Signed $0.6 mln new pharmaceutical trial contract.Signed a new contract to supply sphygmocor systems and clinical trial support services to a major international pharmaceutical company.  Full Article

BRIEF-Atcor Medical secures new pharmaceutical trials contracts

* Signed three new contracts to supply Sphygmocor systems and clinical trial support services Source text for Eikon: Further company coverage: